Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Rectal Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Sarcoma 8 Stomach Neoplasms 7 Esophageal Neoplasms 7 Breast Neoplasms 7 Neoplasms 5 Lung Neoplasms 5 Hypopharyngeal Neoplasms 5 Carcinoma, Hepatocellular 5 Recurrence 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasm Metastasis 4 Thyroid Neoplasms 3 Nasopharyngeal Carcinoma 3 Melanoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Glioma 3 Glioblastoma 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Osteosarcoma 2 Mouth Neoplasms 2 Hyperthermia 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2

Interventions

trametinib 1 dabrafenib 1 Surgical Procedures, Operative 1 Pharmaceutical Preparations 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rare Malignant Neoplasm × Surgical Procedures, Operative × Clear all

NCT06872853 2025-03-12

RAC

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Rare Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡